N4 Pharma (LON:N4P) Shares Up 25.7% – What’s Next?

N4 Pharma Plc (LON:N4P)’s share price was up 25.7% on Wednesday . The stock traded as high as GBX 0.75 ($0.01) and last traded at GBX 0.66 ($0.01). Approximately 9,900,133 shares were traded during mid-day trading, an increase of 327% from the average daily volume of 2,320,520 shares. The stock had previously closed at GBX 0.53 ($0.01).

N4 Pharma Price Performance

The company has a debt-to-equity ratio of 1.62, a current ratio of 22.73 and a quick ratio of 7.28. The firm has a market cap of £2.57 million, a price-to-earnings ratio of -55.00 and a beta of -0.37. The stock’s fifty day moving average price is GBX 0.62 and its 200-day moving average price is GBX 0.57.

About N4 Pharma

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.